ARCT Q4 2020 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena

ARCTArcturus Therapeutics Holdings Inc.

$210M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-24.6% YoY

Gross Profit

-$20M-900.3% margin

Operating Income

-$31M-1388.8% margin

Net Income

-$31M-1389.8% margin

EPS (Diluted)

$-1.19

QoQ Revenue Growth

-4.1%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$476M

Total Liabilities

$80M

Stockholders' Equity

$397M

Cash & Equivalents

$463M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$3M	-24.6%
Gross Profit	-$20M	-$9M	-123.2%
Operating Income	-$31M	-$11M	-187.3%
Net Income	-$31M	-$11M	-183.0%